domain | apostlelab.com |
summary | **Summary:**
- **Key Members:** The management team at Apostle Labs consists of former members of the clinical trial teams for Sofosbuvir (marketed as Sovaldi), owned by Gilead Sciences (NASDAQ: GILD). They were involved from 2011 to 2016, supporting clinical studies, genomic investigations, and FDA submissions for Sofosbuvir, its successor Harvoni/Ledipasvir and Sofosbuvir.
- **Clinical Trial:** A phase I study was conducted using an individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors. Interim results showed decreased circulating tumor DNA (ctDNA) in patients with prolonged overall survival (OS).
- **Methodology:** Cell-free DNA (cfDNA) was isolated from the entire plasma volume of a single draw using the Apostle MiniMax cfDNA Isolation kit by ApostleBio.
- **Publication:** The phase I clinical study was published in Nature Medicine, involving a joint clinical team from Gritstone Oncology, Columbia University Medical Center, Mayo Clinic, Memorial Sloan Kettering Cancer Center (MSKCC), MD Anderson Cancer Center, and other institutions. |
title | Apostle Lab CRO Services |
description | Apostle Lab CRO Services |
keywords | apostle, laboratory, study, phase, health, team, plasma, high, state, medical, isolation, services, public, trial, university, using, cost |
upstreams |
|
downstreams |
|
nslookup | A 50.63.143.238 |
created | 2025-03-26 |
updated | 2025-05-10 |
summarized | 2025-05-10 |
|
|